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Background: air pollution has been associated with cardiovascu-
lar mortality, but it remains unclear as to whether specific pollut-
ants are related to specific cardiovascular causes of death. Within 
the multicenter european Study of cohorts for air Pollution effects 
(eScaPe), we investigated the associations of long-term exposure 
to several air pollutants with all cardiovascular disease (cVD) mor-
tality, as well as with specific cardiovascular causes of death.
Methods: Data from 22 european cohort studies were used. Using 
a standardized protocol, study area–specific air pollution exposure 
at the residential address was characterized as annual average con-
centrations of the following: nitrogen oxides (nO2 and nOx); par-
ticles with diameters of less than 2.5 μm (PM2.5), less than 10 μm 
(PM10), and 10 μm to 2.5 μm (PMcoarse); PM2.5 absorbance estimated 
by land-use regression models; and traffic indicators. We applied 
cohort-specific cox proportional hazards models using a standard-
ized protocol. random-effects meta-analysis was used to obtain 
pooled effect estimates.
Results: the total study population consisted of 367,383 participants, 
with 9994 deaths from cVD (including 4,992 from ischemic heart 
disease, 2264 from myocardial infarction, and 2484 from cerebro-
vascular disease). all hazard ratios were approximately 1.0, except 
for particle mass and cerebrovascular disease mortality; for PM2.5, 
the hazard ratio was 1.21 (95% confidence interval = 0.87–1.69) per 
5 μg/m3 and for PM10, 1.22 (0.91–1.63) per 10 μg/m
3.
Conclusion: in a joint analysis of data from 22 european cohorts, 
most hazard ratios for the association of air pollutants with mortality 
from overall cVD and with specific cVDs were approximately 1.0, 
with the exception of particulate mass and cerebrovascular disease 
mortality for which there was suggestive evidence for an association.
(Epidemiology 2014;25: 368–378)
Cohort studies assessing effects of long-term exposure to air pollution on cardiovascular mortality have generally 
found increased risks.1–4 Studies in the United States have 
mostly reported associations for particles with diameters of 
less than 2.5 μm (PM2.5),
5 whereas studies in europe (includ-
ing studies in the netherlands,6 France,7 norway,2 Denmark,8 
United Kingdom,9 and italy)10 have also reported associa-
tions with long-term exposure to nitrogen oxides (nO2 and 
nOx), which are more related to traffic pollutants than particle 
mass. effect estimates differ across studies, with some stud-
ies showing little or no association of various air pollutants 
with all cardiovascular mortality.6,9,11–13 there is therefore an 
interest in investigating the mortality effects of a range of air 
pollutants.
the category of cardiovascular diseases (cVDs) is 
broad, and it is unlikely that the risk associated with air pollu-
tion exposure is uniform for the specific cardiovascular mor-
tality causes. However, only a few studies have investigated 
specific causes of cardiovascular mortality, including isch-
emic heart disease and cerebrovascular disease.1,2,8,14–16
the aim of the current study was to investigate the 
effects of long-term exposure to air pollution on all cardio-
vascular mortality, as well as the more specific causes of 
ischemic heart disease mortality, myocardial infarction (Mi) 
mortality, and cerebrovascular disease mortality, for a range 
of air pollution measures. in the framework of the collab-
orative european Study of cohorts for air Pollution effects 
(eScaPe), data from 22 ongoing cohort studies were used, 
with a standardized exposure assessment of particle mass 
and nitrogen oxides.
METHODS
the association between air pollution and cardiovas-
cular mortality was analyzed in each cohort separately, fol-
lowing the standardized analysis protocol of the eScaPe 
study.17 a standardized statistical protocol and Stata script 
were used, as explained in a training workshop for all local 
analysts. cohort-specific results were sent to the coordinat-
ing institute (iraS, Utrecht University) for central evaluation. 
We combined cohort-specific effect estimates by random-
effects meta-analysis. Pooling of the cohort data was not pos-
sible due to data transfer and privacy issues. random-effects 
 meta-analysis has the advantage of taking into account inter-
area and intercohort differences not entirely addressed by the 
available confounders.
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Study Populations
twenty-two ongoing cohorts from 13 countries across 
europe were included (table 1, and eappendix 1; http://links.
lww.com/eDe/a767). all cohorts were included samples 
from the general population. the study areas of most cohorts 
consisted of a large city with surrounding smaller rural com-
munities. Some (multicenter) cohorts included large regions 
of the country, such as ePic-MOrgen in the netherlands, 
Salia in the ruhr area in germany, ePic-Oxford covering 
much of the United Kingdom, the VHM&PP cohort in aus-
tria, and SaPalDia in three cities in Switzerland. the use 
of cohort data in eScaPe was approved by the local ethical 
and data protection authorities. each cohort study followed 
the rules for ethics and data protection set up in the country in 
which it was based.
Mortality Outcome Definition
in all cohorts, follow-up was based on linkage to mor-
tality registries. Outcomes were defined on the basis of the 
underlying cause of death recorded on death certificates: 
all cVD mortality (International Classification of Diseases 
[ICD]-9: 400–440; ICD-10: i10-i70), ischemic heart disease 
mortality (ICD-9: 410–414; ICD-10: i20-i25), Mi mortality 
(ICD-9: 410; ICD-10: i21, i22), and cerebrovascular disease 
mortality (ICD-9: 430–438; ICD-10: i60-i69) (eappendix 2; 
http://links.lww.com/eDe/a767).
Exposure Assessment
air pollution concentrations at the baseline residential 
addresses of study participants were estimated by  land-use 
regression models following a standardized procedure 
described elsewhere.18,19 in brief, air pollution was monitored 
for 1 year between October 2008 and May 2011 in all study 
areas to obtain the following annual average concentrations: 
nO2 and nOx; particles with aerodynamic diameters of less 
than 2.5 μm (PM2.5) and less than 10 μm (PM10) plus PM2.5 
absorbance (determined as the reflectance of PM2.5 filters).
20,21 
PMcoarse was calculated as PM10 minus PM2.5. PM and nOx 
were both measured in 19 of the 22 study areas; nOx alone 
was measured in the remaining three areas. Study area–spe-
cific land-use regression models were developed to explain 
the spatial variation of measured annual average air pollution 
concentrations within each area using traffic and land-use 
predictor variables from a geographic information System. 
the results of the land-use regression models were then used 
to estimate ambient air pollution concentration at the partici-
pants’ baseline addresses. in addition to air pollution concen-
trations, traffic intensity on the nearest road (vehicles per day) 
and total traffic load (intensity × length) on all major roads 
within a 100-m buffer were used as indicators of exposure. 
a detailed description of exposure-assessment procedures, 
including back-extrapolation of concentrations to the base-
line year and fit of land-use regression models, is presented in 
eappendix 3 (http://links.lww.com/eDe/a767).
Statistical Analyses
Cohort-specific Analyses
cox proportional hazards models were used for the 
cohort-specific analyses. We used age as the time scale 
because of evidence that this better adjusts for potential con-
founding by age.22 censoring occurred at the time of death 
for non-cVD causes, emigration, loss to follow-up for other 
reasons, or at end of follow-up, whichever came first. air pol-
lution exposure was analyzed as a linear variable. information 
on potential confounders was available from questionnaires 
at baseline.
a priori, we specified three confounder models with 
increasing level of adjustment. confounder models were 
decided based on previous cohort studies of air pollution 
and mortality, as well as availability of data in a majority 
of the cohorts. Model 1 included only age (time axis), sex, 
and calendar time (year(s) of enrollment). Model 2 added 
 individual-level variables: smoking status (never/former/cur-
rent), smoking intensity, smoking duration, environmental 
tobacco smoke, fruits intake, vegetables intake, alcohol con-
sumption (linear and squared term), body mass index (BMi) 
(linear and squared term), educational level (low, medium, 
or high), occupational class (white/blue collar classifica-
tion), employment status, and marital status. Model 3 added 
to Model 2 area-level socioeconomic status (SeS) variables 
(mostly mean income of neighborhood or municipality). 
Model 3 was selected as the main confounder model. Only 
subjects with complete information for Model 3 variables 
were included in the analyses.
in sensitivity analyses, we added prevalent hyperten-
sion, physical activity, diabetes mellitus, and cholesterol level 
to Model 3. extended confounder models were used in sensi-
tivity analyses because some potential effect of air pollution 
might be mediated by hypertension, diabetes mellitus, and 
cholesterol level.
We further evaluated the impact of the addition of mod-
eled road traffic noise to Model 3 because noise and air pol-
lution have been shown to be correlated and may both affect 
cVD mortality. road traffic noise was modeled at the highest 
exposed facade at the baseline address (eappendix 3; http://
links.lww.com/eDe/a767). noise was used as continuous 
variable and as categorical variable (5 dB categories).1
effect modification by a priori-specified variables was 
investigated by stratified analyses for age during follow-up 
(<60, 60–75, ≥ 75 year), sex, smoking status, educational 
level, fruits intake (<150, 150–300, ≥300 g/day), and BMi 
(<25, 25–30, ≥ 30 kg/m2). these variables were selected based 
on previous studies.5,23
We tested whether back-extrapolation of the air pollu-
tion concentrations to the baseline year affected the results 
(details in eappendix 3; http://links.lww.com/eDe/a767). 
Sensitivity analyses restricted to subjects who did not move 
during follow-up were conducted. We conducted analyses 
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without the large austrian cohort.We checked for spatial clus-
tering of residuals of the models using random effects of the 
spatial area units (often neighborhood or municipality) in each 
cohort. the two traffic indicator variables were analyzed in 
combination with background nO2 concentration.
all cohort-specific analyses were done in Stata ver-
sions 10 to 12 (Statacorp, college Station, tX) except 
models with random effects, which were done using r soft-
ware (r Foundation for Statistical computing, 2004 [iSBn 
 3-900051-00-3], Vienna, austria).
Meta-analysis
Meta-analyses of cohort-specific effect estimates were 
conducted using the DerSimonian–laird24 method with ran-
dom effects. Hazard ratios (Hrs) and 95% confidence inter-
vals (cis) were calculated for fixed increments. Heterogeneity 
between cohorts was quantified by the I2 statistic and tested by 
the χ2 test from cochran’s Q statistic.25
effect modification was tested by meta-analysis of the 
pooled estimates from the various strata, and by computing 
the χ2 test of heterogeneity.
We tested whether effect estimates differed for cohorts 
for which the variance explained by the land-use regression 
model cross-validation was smaller or larger than 60% for 
PM2.5. in addition, we tested whether effect estimates dif-
fered by region of europe (“north”: Sweden, norway, Fin-
land, Denmark; “West and Middle”: United Kingdom, the 
netherlands, germany, France, austria, and Switzerland; and 
“South”: italy and greece). all meta-analyses were conducted 
in Stata, version 12 (Statacorp).
RESULTS
Characteristics of the Study Population
the total study population consisted of 367,383 par-
ticipants contributing 5,119,317 person-years at risk (average 
time of follow-up = 13.9 years). Of the participants, 29,076 
died from a natural cause during follow-up, with 9994 deaths 
due to cVD (4992 to ischemic heart disease, 2264 to Mi, and 
2484 cerebrovascular disease) (table 1). the ratio of specific 
causes to all cVD deaths varied substantially among cohorts. 
cohorts were recruited mostly in the 1990s. cohorts differed 
in the number of participants, the mean baseline age, and the 
availability of information on confounders (table 2, and eap-
pendix 4; http://links.lww.com/eDe/a767). age, sex, smok-
ing status, and area-level SeS were available for all cohorts. 
Smoking intensity and duration were available as continuous 
variables for all cohorts except for the austrian and French. 
the austrian cohort had data on occupation and employment 
status but not on education.
Air Pollution Exposure
air pollution concentrations varied among and within 
study areas (eappendix 5; http://links.lww.com/eDe/a767). 
concentrations showed an increase from northern to southern 
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europe cohorts. the average nO2 concentration ranged from 
5.2 μg/m3 (ePic-Umeå) to 59.8 μg/m3 (SiDria-turin) and 
the average PM2.5 concentration from 6.6 μg/m
3 (SDPP) to 
31.0 μg/m3 (SiDria-turin). Median differences between 
area-specific 5th and 95th percentiles in nO2 and PM2.5 con-
centrations were 21.1 and 4.3 μg/m3, respectively. contrasts 
were within-city contrasts for most study areas but could also 
include between-city contrasts for the cohorts covering larger 
geographical areas. correlations between exposure measures 
were moderate to high in each cohort (eappendix 6; http://
links.lww.com/eDe/a767).
Main Results
Most Hrs for the association between mortality out-
comes and the air pollutants were approximately 1.0 (table 3, 
Figure, and eappendix 7; http://links.lww.com/eDe/a767), 
with the exception of the association of particulate mass and 
cerebrovascular disease mortality (table 3 and Figure). the 
Hr for PM2.5 was 1.21 (95% ci = 0.87–1.69) per 5 μg/m
3 and 
for PM10 the Hr was 1.22 (0.91–1.63) per 10 μg/m
3. in addi-
tion, associations between all outcomes and traffic intensity 
on the nearest road were slightly increased; the Hr for total 
cVD mortality was 1.02 (0.99–1.05) per 5000 motor vehicles 
per day, an association that remained after adjustment for 
noise (eappendix 8; http://links.lww.com/eDe/a767).
Hrs for confounder Model 1 (adjusted only for calendar 
year and sex) were highest; after adjustment for  individual-level 
confounders, Hrs decreased. Sensitivity analyses showed 
that smoking variables were primarily responsible for this 
decrease. inclusion of area-level SeS variables led to a small 
further decrease in Hrs.
no heterogeneity among cohorts was found for total 
cVD mortality, except for the Hrs for traffic intensity on 
major roads in a 100-m buffer. Hrs for random-effects 
(default method) and fixed-effects cVD meta-analyses were 
similar (data not shown). For the more specific causes, low to 
moderate heterogeneity was found (I2 < 50%).
Sensitivity Analyses
additional adjustment for hypertension and physi-
cal activity, diabetes mellitus and cholesterol, and noise 
did not change the pooled Hrs compared with the main 
model Hrs (eappendix 8; http://links.lww.com/eDe/
a767).  Back-extrapolation for nO2 was possible in 18 
cohorts, whereas back-extrapolation for PM10 was possible 
for seven cohorts spread over europe. Hrs were not differ-
ent between the back-extrapolated concentrations at baseline 
in the year of recruitment and the concentrations based on 
2008–2011 measurements. Pooled Hrs for cVD mortality 
for  back-extrapolated nO2 concentrations based on the dif-
ference and the ratio method were 1.02 (95% ci = 0.97–1.07) 
and 1.01 (0.98–1.05)—essentially the same as the 1.02 (0.97–
1.07) for the main eScaPe exposure for the 18 cohorts with 
back-extrapolated nO2 concentrations. For cerebrovascular 
disease mortality, pooled Hrs for back-extrapolated PM10 
concentrations based on the difference and the ratio method 
were 1.36 (0.92–2.02) and 1.22 (0.93–1.59) also the same 
as the 1.21 (0.79–1.85) for the main eScaPe exposure for 
the seven cohorts with back-extrapolated PM10 concentra-
tions. analyses restricted to subjects who did not move dur-
ing follow-up resulted in similar Hrs as for the main analyses 
(data not shown). Hrs for total cVD mortality without the 
influential austrian cohort were similar to those from the main 
analyses. Hrs for cerebrovascular disease mortality for PM2.5 
and PM10 increased to 1.32 (0.93–1.89) and 1.30 (0.96–1.77), 
respectively. Hrs with and without accounting for spatial 
clustering of residuals were similar. PM2.5 effect estimates for 
cerebrovascular disease mortality were similar for the cohorts 
for which the variance explained by land-use regression 
model cross-validation was smaller or larger than 60%: 1.24 
(0.71–2.15) (n = 6) and 1.22 (0.78–1.92) (n = 12), respec-
tively. PM2.5 effect estimates for cerebrovascular disease mor-
tality were also not statistically different among the cohorts in 
different regions. For the other pollutants also, effect estimates 
did not differ based on validation R2 or region.
Effect Modification
For none of the evaluated variables, was there an indica-
tion of effect modification, except for PM2.5, for which men 
had higher Hrs than women (eappendix 9; http://links.lww.
com/eDe/a767). For nO2, there was no difference in Hrs 
between men and women.
DISCUSSION
We found that most Hrs for the association between air 
pollutants and mortality from overall cVD and specific cVDs 
were approximately 1.0, with the exception of particulate 
mass and cerebrovascular disease mortality for which there 
was suggestive evidence for an association.
an association between PM2.5 exposure and overall car-
diovascular mortality was first identified in the Harvard Six 
cities study (risk ratio [rr] = 1.28 [95% ci = 1.13–1.44] 
per 10 μg/m3),4 and the american cancer Society study 
(rr = 1.09 [1.03–1.16] per 10 μg/m3),3 both from the United 
States. Overall, subsequent cohort studies have confirmed 
these associations.5,23 a recent review documented large het-
erogeneity of effect estimates across studies, with several 
studies showing no association.23 a recent study of a national 
United Kingdom cohort found associations between ambient 
air pollution and all-cause mortality, but associations were 
approximately 1.0 for cardiovascular mortality.9
associations between exposure to nO2 or elemental 
carbon (which correlates highly with PM2.5 absorbance) and 
overall cardiovascular mortality were observed in studies con-
ducted in europe, Japan, canada, and the United States.6–8,26–31 
the number of studies on the association between long-term 
coarse particle exposure and cardiovascular mortality is still 
small, and there is no clear evidence that coarse particles are 
associated with overall cardiovascular mortality.3,11
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the diversity of diseases included in the broad cat-
egory of cVDs makes it unlikely that the risk associated with 
air pollution exposure is the same for all diseases.5 Stud-
ies have therefore evaluated specific cardiovascular causes, 
with focus on ischemic heart disease, and cerebrovascular 
disease mortality. Most studies investigating ischemic heart 
disease mortality found increased risks for PM2.5 or PM10 
exposure,14,15,32–34 and for nO2 or nOx exposure.
2,8,29–31 a 
few studies, however, found no association between air pollu-
tion exposure and ischemic heart disease mortality.1,11 Fewer 
TABLE 3. Association of Exposure to Air Pollution and Traffic Indicators with Mortality Due to CVD, Ischemic Heart Disease, 
MI, and Cerebrovascular Disease: Results from Random-effects Meta-analyses (HR [95% CI]) and I2 (P Value) of Test for 
Heterogeneity of Effect Estimates Among Cohorts Using Main Confounder Models 1, 2, and 3a
Exposure
Model 1b
HR (95% CI)
Model 2b
HR (95% CI)
Model 3b
HR (95% CI) I2 (P)c
Total CVD deaths
 PM2.5
d 1.18 (1.00–1.38) 1.04 (0.93–1.17) 0.99 (0.91–1.08) 0 (0.48)
 PM2.5 absorbance
d 1.09 (0.95–1.25) 0.99 (0.91–1.08) 0.97 (0.89–1.06) 0 (0.67)
 PM10
d 1.10 (0.95–1.26) 1.04 (0.92–1.16) 1.02 (0.92–1.14) 20.2 (0.21)
 PM coarsed 1.11 (0.95–1.30) 1.04 (0.92–1.17) 1.02 (0.91–1.13) 26.9 (0.14)
 nO2 1.07 (1.00–1.14) 1.03 (0.97–1.08) 1.01 (0.97–1.06) 20.1 (0.20)
 nOx 1.06 (1.02–1.11) 1.03 (0.99–1.07) 1.02 (0.99–1.06) 0 (0.53)
 traffic intensity on the nearest roade 1.03 (1.00–1.06) 1.02 (0.99–1.06) 1.02 (0.99–1.05) 30.3 (0.10)
 traffic intensity on major roads 100-m bufferf 1.02 (0.93–1.12) 1.00 (0.90–1.11) 0.99 (0.89–1.11) 55.5 (0.001)
Ischemic heart disease deaths
 PM2.5
d 1.09 (0.87–1.37) 1.00 (0.78–1.27) 0.98 (0.74–1.30) 40.3 (0.04)
 PM2.5 absorbance
d 1.07 (0.86–1.32) 0.99 (0.82–1.20) 0.98 (0.78–1.23) 34.2 (0.07)
 PM10
d 0.98 (0.85–1.14) 0.94 (0.80–1.10) 0.93 (0.77–1.13) 34.7 (0.07)
 PM coarsed 0.98 (0.81–1.19) 0.92 (0.77–1.10) 0.92 (0.77–1.11) 41.3 (0.03)
 nO2 1.05 (0.96–1.14) 1.00 (0.92–1.09) 1.00 (0.91–1.09) 34.3 (0.06)
 nOx 1.06 (0.99–1.12) 1.02 (0.96–1.09) 1.02 (0.95–1.09) 20.3 (0.19)
 traffic intensity on the nearest roade 1.03 (1.00–1.06) 1.02 (0.99–1.06) 1.02 (0.99–1.06) 4.3 (0.40)
 traffic intensity on major roads 100-m bufferf 1.05 (0.92–1.19) 1.02 (0.89–1.17) 1.02 (0.88–1.18) 55.4 (0.001)
MI deaths
 PM2.5
d 1.07 (0.82–1.41) 0.98 (0.72–1.33) 0.96 (0.70–1.32) 28.7 (0.13)
 PM2.5 absorbance
d 1.11 (0.82–1.50) 0.99 (0.77–1.28) 0.97 (0.75–1.25) 19.9 (0.22)
 PM10
d 0.97 (0.84–1.12) 0.95 (0.82–1.10) 0.94 (0.81–1.09) 0 (0.66)
 PM coarsed 0.95 (0.76–1.19) 0.89 (0.73–1.09) 0.88 (0.71–1.10) 35.9 (0.07)
 nO2 1.03 (0.92–1.14) 0.98 (0.89–1.08) 0.98 (0.88–1.09) 26.9 (0.12)
 nOx 1.03 (0.94–1.12) 0.99 (0.91–1.08) 0.99 (0.90–1.07) 19.0 (0.21)
 traffic intensity on the nearest roade 1.04 (1.00–1.08) 1.03 (0.99–1.07) 1.03 (0.99–1.07) 0 (0.71)
 traffic intensity on major roads 100-m bufferf 1.08 (0.94–1.25) 1.05 (0.90–1.22) 1.04 (0.89–1.22) 36.9 (0.05)
Cerebrovascular disease deaths
 PM2.5
d 1.34 (0.94–1.91) 1.28 (0.91–1.80) 1.21 (0.87–1.69) 38.0 (0.05)
 PM2.5 absorbance
d 1.23 (0.91–1.66) 1.12 (0.86–1.47) 1.01 (0.82–1.24) 7.0 (0.37)
 PM10
d 1.33 (0.99–1.79) 1.28 (0.94–1.74) 1.22 (0.91–1.63) 49.4 (0.009)
 PM coarsed 1.29 (0.96–1.72) 1.22 (0.93–1.62) 1.17 (0.90–1.52) 46.4 (0.02)
 nO2 1.09 (0.96–1.23) 1.05 (0.94–1.18) 1.01 (0.93–1.10) 16.7 (0.24)
 nOx 1.07 (0.95–1.19) 1.04 (0.93–1.16) 1.00 (0.93–1.08) 14.4 (0.27)
 traffic intensity on the nearest roade 1.03 (0.99–1.08) 1.03 (0.99–1.07) 1.02 (0.98–1.07) 0 (0.60)
 traffic intensity on major roads 100-m bufferf 1.07 (0.94–1.21) 1.05 (0.92–1.19) 1.04 (0.90–1.19) 26.0 (0.14)
aHrs are presented for the following increments: 10 μg/m3 for nO2, 20 μg/m
3 for nOx, 5 μg/m
3 for PM2.5, 10
−5 m−1 for PM2.5 absorbance, 10 μg/m
3 for PM10, 5 μg/m
3 for PMcoarse, 
5000 motor vehicles per day for the traffic intensity on the nearest road, and 4,000,000 motor vehicles*m/day for the total traffic load on all major roads within a 100-m buffer.
bModel 1: adjusted for sex and calendar time: Model 2: as in Model 1, also adjusting for smoking status, smoking intensity, smoking duration, environmental tobacco smoke, fruit 
intake, vegetable intake, alcohol consumption, body mass index, educational level, occupational class, employment status, and marital status: Model 3: as in Model 2, also adjusting 
for area-level socioeconomic status.
cI2 and cochran’s test for heterogeneity for Model 3.
dPM not available for ePic-Umeå, ePic-Varese, and ePic-San Sebastian. For e3n and SaPalDia, PM was available for part of the cohort (table 1).
enot available for ePic-Varese and ePic-San Sebastian.
fnot available for ePic-Varese.
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studies have investigated cerebrovascular disease mortality. in 
the Dutch cohort study and in the Women’s Health initiative 
Study, a strong association was found between cerebrovascular 
disease mortality and black smoke and PM2.5, respectively.
1,15 
in contrast, no such association was found in the american 
cancer Society study,14 a norwegian cohort study,2 a recent 
Danish cohort study,8 and recent large canadian population-
based studies.30,34
in previous cohort studies assessing effects of  long-term 
exposure to air pollution on mortality, it has generally been 
found that effect estimates were larger for cardiovascular 
mortality than for all-cause or natural-cause mortality,23 with 
a few exceptions.6,9,35,36 However, the heterogeneity in effect 
estimates across studies was much larger for cVD mortality 
than for natural-cause mortality.23 in our study, we found the 
opposite; in the same cohorts, using the same exposure and 
statistical methods, an association of natural-cause mortal-
ity with PM2.5 (Hr = 1.07 [95% ci = 1.02–1.13] per 5 μg/
m3) was found.37 We do not have a clear explanation for the 
lack of an association with cardiovascular mortality within the 
eScaPe project, whereas we did find an association with all 
 natural-cause mortality. this discrepancy could be due to the 
fact that cardiovascular causes of death contributed no more 
than 30% of all deaths in 15 of the 22 cohorts. in the Harvard 
Six cities and in the american cancer Society studies, par-
ticipants were born on average several decades earlier than in 
most of our cohorts, and the relative contribution of cardio-
vascular mortality to total mortality in these two cohorts was 
much larger.
We speculate that changes in cardiovascular risk pro-
files over time (eg, reduced smoking and increased medication 
and medical treatment)38 have altered the relation between 
air pollution and cVD mortality. there is some support for 
this speculation in a recent german study showing stronger 
association for early-period versus later-period exposures.31 
these changes over time result in a lower fatality rate for car-
diovascular events, suggesting that risk factors may increas-
ingly have a different association with incident cardiovascular 
events and cardiovascular mortality.38 We found an associa-
tion between PM10 and incident (fatal plus not-fatal) coronary 
events (Hr = 1.12 [95% ci = 1.01–1.25] for an increase of 10 
μg/m3 in PM10) in a subset of 11 cohorts within the eScaPe 
FIGURE. Adjusted  association  of  cere-
brovascular  disease  mortality  with  expo-
sure  to  (A)  PM2.5  and  (B)  NO2:  Results 
from   cohort-specific  analyses  and  from 
 random-effects  meta-analyses.  Numbers 
between  brackets  represent  the  weight  of 
each cohort in the  meta-analysis. HRs are pre-
sented per 5 μg/m3 for PM2.5 and per 10 μg/
m3 for NO2. PM not available for EPIC-Umeå, 
EPIC-Varese, and EPIC-San Sebastian. For E3N 
and SAPALDIA, PM was available  for part of 
the cohort (Table 1).
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project, using the same exposure and statistical methods.39 
Furthermore, in the same subset of 11 cohorts, PM2.5 was 
associated with stroke incidence (Hr = 1.19 [95% ci = 0.88–
1.62]) (M. Stafoggia, unpublished data, 2014). For the inci-
dence of both coronary events and stroke, the number of cases 
was approximately six times higher than the number of isch-
emic heart disease and cVD deaths, respectively, in our analy-
sis. incident events may be less affected by medication use 
than cardiovascular deaths, which are likely often preceded 
by nonfatal events. this suggests that a large number of inci-
dent coronary and stroke events do not lead to cardiovascular 
death soon after the event. compared with our natural-cause 
mortality analysis, we observed more substantial heterogene-
ity of effect estimates across cohorts, especially for the more 
specific causes.
another limitation is that we have to rely on data from 
mortality registries. there may be coding differences in death 
certificates among countries and among eScaPe study 
areas. Such differences might have contributed to the het-
erogeneous results among eScaPe cohorts. Heterogeneity 
in effect estimates due to coding differences might also have 
affected the overall pooled analyses, possibly leading to the 
lack of an association with cardiovascular mortality. We did 
observe increased effect estimates in models adjusted only for 
age and sex; these estimates were reduced after adjustment 
for confounders. it is unlikely that we over-adjusted our mod-
els, because our confounder models were similar to previous 
studies and because smoking (a well-established risk factor) 
was mainly responsible for the drop in effect estimates. We 
further found no evidence for cVD mortality associations in 
never-smokers.
cis were small for overall cVD mortality and wider 
for specific causes. the increased Hrs for cerebrovascular 
disease mortality could be a chance finding among the many 
associations studied. However, the consistency across models 
and the coherence with the stroke incidence analysis support 
these associations.
One source of variability of effect estimates among pre-
vious studies is likely related to varying degrees of exposure 
misclassification. a strength of eScaPe is that air pollution 
exposure assessment within the eScaPe study areas was 
conducted in a standardized way.
a limitation of our study is that the land-use regres-
sion models used for exposure assessment were based on air 
pollution measurements in the period 2008–2011, whereas 
the cohort studies included in eScaPe started in the past 
(1985–2007, with most studies starting in the mid-1990s). 
analyses using exposures back-extrapolated to the recruit-
ment date showed similar Hrs. Four recent studies in the 
netherlands,40 rome,41 United Kingdom,42 and Vancouver43 
have shown that, for periods up to 10 years and longer, spatial 
air pollution contrasts often remained the same, even with a 
decrease in concentrations over time. thus, land-use regres-
sion models based on current air pollution data may be valid 
predictors of historic spatial contrasts. Measurement error is 
an unlikely explanation of the lack of associations, because we 
did observe an association with natural-cause mortality using 
the same exposure variables and the same set of cohorts.
in conclusion, most Hrs for the association of air pol-
lutants with mortality from overall cardiovascular and from 
specific cVDs were approximately 1.0 in 22 european cohort 
studies, with the exception of particulate mass and cerebro-
vascular disease mortality for which there was suggestive evi-
dence for an association.
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